rs143907628
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The ENST00000299314.12(GNPTAB):c.500T>A(p.Ile167Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000443 in 1,614,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000299314.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNPTAB | NM_024312.5 | c.500T>A | p.Ile167Asn | missense_variant | 5/21 | ENST00000299314.12 | NP_077288.2 | |
GNPTAB | XM_011538731.3 | c.419T>A | p.Ile140Asn | missense_variant | 5/21 | XP_011537033.1 | ||
GNPTAB | XM_006719593.4 | c.500T>A | p.Ile167Asn | missense_variant | 5/19 | XP_006719656.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNPTAB | ENST00000299314.12 | c.500T>A | p.Ile167Asn | missense_variant | 5/21 | 1 | NM_024312.5 | ENSP00000299314 | P1 | |
GNPTAB | ENST00000549940.5 | c.500T>A | p.Ile167Asn | missense_variant | 5/11 | 1 | ENSP00000449150 | |||
GNPTAB | ENST00000552681.1 | c.134T>A | p.Ile45Asn | missense_variant | 1/3 | 1 | ENSP00000449217 | |||
GNPTAB | ENST00000550352.1 | n.294T>A | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000462 AC: 116AN: 251338Hom.: 0 AF XY: 0.000449 AC XY: 61AN XY: 135840
GnomAD4 exome AF: 0.000441 AC: 645AN: 1461836Hom.: 0 Cov.: 31 AF XY: 0.000411 AC XY: 299AN XY: 727218
GnomAD4 genome AF: 0.000460 AC: 70AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74484
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Pseudo-Hurler polydystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 05, 2016 | - - |
Mucolipidosis type II Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at